期刊文献+

复方皂矾丸治疗骨髓增生异常综合征的临床照研究 被引量:4

A Clinical Control Study to Assess the Treatment Effects of Compound Zaofan Pill on Myelodysplastic Syndrome
暂未订购
导出
摘要 目的 :探讨复方皂矾丸治疗骨髓增生异常综合征的临床疗效。方法 :用前瞻性设置对照的研究方法将纳入研究的 31例病例分为治疗组与对照组 ,分别用复方皂矾丸和用全反式维甲酸、维生素B6、或 /和小剂量阿糖胞甙治疗 ,随访观察疗效。结果 :治疗组基本缓解 1例、部分缓解及进步 9例、无效 4例 ,总有效率 71 4 % ,明显高于对照组的 2 3 5 % (两组比较有统计学意义 ,P <0 0 0 1 )。结论 :复方皂矾丸为纯中药制剂、治疗骨髓增生异常综合征疗效较好 ;复方皂矾丸无明显毒副作用、价格较低廉 。 Objective:To investigate the therapeutic effects of compound Zaofan pill on myelodysplastic syndrome(MDS).Method:A clinical control study,the eligible subjects was divided into two groups,while the research group was given compound Zaofan pill,and the control group was given all-trans retinoic acid(ATRA),vitamin B6,or/and low dose ara-C.Results:There was only 1 obvious remission case,and 9 improved the cases in the research group with a total effective rate of 71 4%,demonstrating a statistical significance as compared with the effective rate of 23 5% in the control group( P <0 001).Conclusion:Compound Zaofan pill,a preparation of pure chinese medicine,showed a good curative effect on MDS,and compound Zaofan pill gave a low cost and no severe side-effects,so it was worthy of using on MDS.
出处 《华西医学》 CAS 2003年第2期193-194,共2页 West China Medical Journal
关键词 复方皂矾丸 骨髓增生异常综合征 对照研究 中医药疗法 Myelodysplastic syndrome Compound Zaofan pill
  • 相关文献

参考文献11

  • 1"复方皂矾丸"临床应用组.复方皂矾丸治疗再生障碍性贫血100例疗效分析[J].中华血液学杂志,2000,21(3):157-157. 被引量:63
  • 2邱仲川,赵琳,陈佩,胡琦,曹妹芳,王运律,应平平,杨懿萍,杨红,杨协珍,吴翰香.补肾复方冲剂影响再生障碍性贫血患者造血祖细胞研究[J].北京中医药大学学报,2001,24(3):55-57. 被引量:15
  • 3梁永生.复方皂矾丸治疗再生障碍性贫血临床疗效评价[J].广州中医药大学学报,2001,18(2):123-124. 被引量:8
  • 4Clulombel L, Auffrag I, Gaugler M H, et al. Expression and function of integrins on hemalopoietic progenitor cell [ J ]. Acta Haematol, 1997; 97:3.
  • 5Ohno R, Naoe T, Hirano M et al. Treatment of myelodysplastic syndromes with all -trans mtinoic acid [J]. Blood, 1993, 81 :1152.
  • 6Koeffler HP, Hirji K, Itri L. 1.25 - dihydroxyvitamin D3: in vivo and in vitro effects of human preleukemic and leukemic cells[J]. Cancer Treat Rep, 1985; 69:1399.
  • 7Greenberg P, Taylor K, Larson R et al.Phase Ⅲ randomized muhicenter trial of recombinant human G - CSF in MDS [ J].Blood, 1993; 82 (suppl 1) :196a.
  • 8Ganser A, Ottmann OG, Seipeh Get al.Effect of long - term treatment with recombinant human interleukin - 3 in patient with myelodysplastic syndromes [ J ]. Leukemia,1993; 7:696.
  • 9Gordon MS, Nemunaitis J, Hoffman R et al. Phase I trial of subcutaneous recombinant human interleukin - 6 in patients with myelodysplasia and thrombocytopenia [ J ].Blood,1992; 80 (suppl 1) :249a.
  • 10Schouten HC, Vellenga E, van Rhenen D,et al. Recombinant human erythropoietin for patients with a myelodysplastic syndrome[J]. Blood, 1990; 76:317.

二级参考文献11

  • 1储榆林,邵宗鸿,郑以州,秦铁军,张益枝,郭彦.110例慢性再生障碍性贫血的疗效分析[J].中华血液学杂志,1994,15(4):192-193. 被引量:34
  • 2第四届全国再生障碍性贫血学术会议.再生障碍性贫血诊断标准[J].中华血液学杂志,1987,(8).
  • 3吴翰香.实用中医血液病学[M].上海:上海中医学院出版社,1989.96.
  • 4刘薏玲 汤晓培 等.再生障碍性贫血患者粒、红祖细胞的观察[J].中华血液学杂志,1987,8(10):602-605.
  • 5储榆林 杨崇礼 等.再生障碍性贫血的治疗研究-三十年治疗经验的回顾[J].中华血液学杂志,1987,8(8):193-196.
  • 6陈贵廷,实用中西医结合诊断治疗学,1991年,556页
  • 7吴翰香,实用中医血液病学,1989年,96页
  • 8中华血液学杂志,1987年,8卷,8期,468,封四页
  • 9储榆林,中华血液学杂志,1987年,8卷,8期,193页
  • 10刘薏玲,中华血液学杂志,1987年,8卷,10期,602页

共引文献71

同被引文献52

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部